PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy

Marcellusi, A.; Bansback, N.; Rao, S.; Cifaldi, M.; Gitto, L.; Giannantoni, P.; Russo, S.; Mennini, F.S.

10.1016/j.jval.2012.08.1386

PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy

Authors: A. Marcellusi
N. Bansback
S. Rao
M. Cifaldi
L. Gitto
P. Giannantoni
S. Russo
F.S. Mennini
Publication date: 2012
Publisher: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

Abstract

Abstract is not available.

Similar works

Full text

Elsevier - Publisher Connector

Provided original full text link

Last time updated on 6/5/2019

This paper was published in Elsevier - Publisher Connector .

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.